Development of Global Pharma CM Sp. z o.o.’ s export activities through promotion on international markets (Q83776): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: summary (P836): Reference_reference_programme_aids:SA.42799 (2015/X): _aid_public: _Article 19 Development project of Global Pharma CM Sp. z o.o. will be carried out as part of the Promotion Programme of Biotechnology and Pharmaceuticals, which is an integral part of the sub-measure 3.3.3 Support for SMEs in the promotion of product brands — Go to Brand (OP IR).As part of the project, the company will promote its products in the following events:— Goods Europ...) |
(Created claim: summary (P836): Reference number of the aid programme: SA.42799(2015/X) Purpose of public aid:_art.19 The project for the development of export activities Global Pharma CM Sp. z o.o. will be implemented as part of the programme of promotion of the biotechnology and pharmaceutical industry, which is an integral part of sub-measure 3.3.3 Support for SMEs in the promotion of product brands – Go to Brand (PO IR). As part of the project, the company will promote its...) |
||||||||||||||
| Property / summary | |||||||||||||||
Reference number of the aid programme: SA.42799(2015/X) Purpose of public aid:_art.19 The project for the development of export activities Global Pharma CM Sp. z o.o. will be implemented as part of the programme of promotion of the biotechnology and pharmaceutical industry, which is an integral part of sub-measure 3.3.3 Support for SMEs in the promotion of product brands – Go to Brand (PO IR). As part of the project, the company will promote its products at the following events: — Vitafoods Europe & Finished Products 2018 and 2019 in Switzerland – CPHI Worldwide 2018 and 2019, which will take place in Spain or on another EU market; — Middle East Pharma Cold Chain Congress 2019 held in the United Arab Emirates, which has been selected as a prospective market, – IPhEB Russia 2019, held in Russia, which has also been chosen as another prospective market, Promotional activities will complement the individual economic mission to the UAE. In addition, the company will also benefit from an advisory service and a training service to acquire the knowledge necessary for effective foreign expansion, in particular in the UAE market. The project will also produce information and promotional materials and a promotional film will be made, and the website will be expanded for foreign clients and additionally translated into Russian. The selection of these markets and activities was based on the existing export experience and the high potential of the markets as well as the indicated trade fair events. The project activities will be co-financed in the form of de minimis aid, and the own contribution will be covered by the company’s own resources. (English) | |||||||||||||||
| Property / summary: Reference number of the aid programme: SA.42799(2015/X) Purpose of public aid:_art.19 The project for the development of export activities Global Pharma CM Sp. z o.o. will be implemented as part of the programme of promotion of the biotechnology and pharmaceutical industry, which is an integral part of sub-measure 3.3.3 Support for SMEs in the promotion of product brands – Go to Brand (PO IR). As part of the project, the company will promote its products at the following events: — Vitafoods Europe & Finished Products 2018 and 2019 in Switzerland – CPHI Worldwide 2018 and 2019, which will take place in Spain or on another EU market; — Middle East Pharma Cold Chain Congress 2019 held in the United Arab Emirates, which has been selected as a prospective market, – IPhEB Russia 2019, held in Russia, which has also been chosen as another prospective market, Promotional activities will complement the individual economic mission to the UAE. In addition, the company will also benefit from an advisory service and a training service to acquire the knowledge necessary for effective foreign expansion, in particular in the UAE market. The project will also produce information and promotional materials and a promotional film will be made, and the website will be expanded for foreign clients and additionally translated into Russian. The selection of these markets and activities was based on the existing export experience and the high potential of the markets as well as the indicated trade fair events. The project activities will be co-financed in the form of de minimis aid, and the own contribution will be covered by the company’s own resources. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: Reference number of the aid programme: SA.42799(2015/X) Purpose of public aid:_art.19 The project for the development of export activities Global Pharma CM Sp. z o.o. will be implemented as part of the programme of promotion of the biotechnology and pharmaceutical industry, which is an integral part of sub-measure 3.3.3 Support for SMEs in the promotion of product brands – Go to Brand (PO IR). As part of the project, the company will promote its products at the following events: — Vitafoods Europe & Finished Products 2018 and 2019 in Switzerland – CPHI Worldwide 2018 and 2019, which will take place in Spain or on another EU market; — Middle East Pharma Cold Chain Congress 2019 held in the United Arab Emirates, which has been selected as a prospective market, – IPhEB Russia 2019, held in Russia, which has also been chosen as another prospective market, Promotional activities will complement the individual economic mission to the UAE. In addition, the company will also benefit from an advisory service and a training service to acquire the knowledge necessary for effective foreign expansion, in particular in the UAE market. The project will also produce information and promotional materials and a promotional film will be made, and the website will be expanded for foreign clients and additionally translated into Russian. The selection of these markets and activities was based on the existing export experience and the high potential of the markets as well as the indicated trade fair events. The project activities will be co-financed in the form of de minimis aid, and the own contribution will be covered by the company’s own resources. (English) / qualifier | |||||||||||||||
point in time: 14 October 2020
| |||||||||||||||
Revision as of 14:19, 14 October 2020
Project in Poland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of Global Pharma CM Sp. z o.o.’ s export activities through promotion on international markets |
Project in Poland financed by DG Regio |
Statements
467,550.0 zloty
0 references
623,400.0 zloty
0 references
75.0 percent
0 references
9 May 2018
0 references
31 December 2019
0 references
GLOBAL PHARMA CM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
0 references
Numer_referencyjny_programu_pomocowego: SA.42799(2015/X) Przeznaczenie_pomocy_publicznej:_art.19 Projekt rozwoju działalności eksportowej Global Pharma CM Sp. z o.o. zostanie zrealizowany w ramach programu promocji branży biotechnologii i farmaceutyków stanowiącego integralną część poddziałania 3.3.3 Wsparcie MŚP w promocji marek produktowych - Go to Brand (PO IR). W ramach projektu spółka będzie promować swoje produkty podczas następujących wydarzeń: - Vitafoods Europe & Finished Products 2018 i 2019 w Szwajcarii - CPhI Worldwide 2018 i 2019, które odbywać się będą w Hiszpanii lub na innym rynku UE; - Middle East Pharma Cold Chain Congress 2019 odbywającego się w Zjednoczonych Emiratach Arabskich, które zostały wybrany jako rynek perspektywiczny, - IPhEB Russia 2019, odbywających się w Rosji, która również została wybrana jako kolejny rynek perspektywiczny, Działania promocyjne dopełniać będzie indywidualna wyjazdowa misja gospodarcza do ZEA. Ponadto firma skorzysta również z usługi doradczej i usługi szkoleniowej, które pozwolą na zdobycie wiedzy niezbędnej do efektywnej ekspansji zagranicznej, w szczególności na rynku ZEA. W ramach projektu wyprodukowane zostaną również materiały informacyjno-promocyjne i zrealizowany zostanie film promocyjny, a strona www zostanie rozbudowana pod kątem klientów zagranicznych i dodatkowo przetłumaczona na język rosyjski. Wybór powyższych rynków oraz działań został dokonany w oparciu o dotychczasowe doświadczenie eksportowe oraz zdiagnozowany wysoki potencjał rynków, jak i wskazanych wydarzeń targowych. Działania w ramach projektu będą współfinansowane w formie pomocy de minimis, a wkład własny zostanie pokryty ze środków własnych firmy. (Polish)
0 references
Reference number of the aid programme: SA.42799(2015/X) Purpose of public aid:_art.19 The project for the development of export activities Global Pharma CM Sp. z o.o. will be implemented as part of the programme of promotion of the biotechnology and pharmaceutical industry, which is an integral part of sub-measure 3.3.3 Support for SMEs in the promotion of product brands – Go to Brand (PO IR). As part of the project, the company will promote its products at the following events: — Vitafoods Europe & Finished Products 2018 and 2019 in Switzerland – CPHI Worldwide 2018 and 2019, which will take place in Spain or on another EU market; — Middle East Pharma Cold Chain Congress 2019 held in the United Arab Emirates, which has been selected as a prospective market, – IPhEB Russia 2019, held in Russia, which has also been chosen as another prospective market, Promotional activities will complement the individual economic mission to the UAE. In addition, the company will also benefit from an advisory service and a training service to acquire the knowledge necessary for effective foreign expansion, in particular in the UAE market. The project will also produce information and promotional materials and a promotional film will be made, and the website will be expanded for foreign clients and additionally translated into Russian. The selection of these markets and activities was based on the existing export experience and the high potential of the markets as well as the indicated trade fair events. The project activities will be co-financed in the form of de minimis aid, and the own contribution will be covered by the company’s own resources. (English)
14 October 2020
0 references
Identifiers
POIR.03.03.03-26-0015/18
0 references